Gan Qingxia, Yang Jingjing, Yang Lu, Yang Yu, Wang Jin, Huang Qinwan
School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China; State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
School of Ethnic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
J Ethnopharmacol. 2026 Feb 10;356:120814. doi: 10.1016/j.jep.2025.120814. Epub 2025 Oct 26.
Traditionally, Calomelas and its preparations have been employed in traditional Chinese medicine (TCM) for the management of scabies and ulcers, exhibiting empirically validated efficacy in wound management protocols, with persistent contemporary utilization. Nevertheless, significant concerns regarding its mercury composition have prompted modern scrutiny. Crucially, a rigorous systematic evaluation of Calomelas and its preparations was still lacking in the existing literature, which hindered their evidence-based application and potential advancement.
This review aims to clarify the medicinal benefits and toxicity of Calomelas and its preparations, supporting the development of modern treatments for refractory skin ulcers while promoting the safe and rational integration of Calomelas-containing preparations into dermatological practice.
Data on Calomelas and its preparations were systematically collated from scientific databases, including PubMed, Google Scholar, ACS Publications, Web of Science, ScienceDirect, CNKI, and WANGFANG.
Calomelas, a mercury-based compound utilized in TCM since the Tang dynasty, has exhibited pronounced therapeutic efficacy in the management of various refractory wound conditions. Several Calomelas-containing preparations, such as Shengji Yuhong Ointment, Babao Pill, Baodu Shengji Powder, Taiyi Ointment, and Calomelas Powder, are routinely utilized in clinical practice for the treatment of diverse skin ulcers and stubborn wounds, including diabetic foot ulcers, postoperative impairments, pressure injuries, and burn wounds. The pharmacological basis of these therapeutic effects relies on their biological activity properties, including antibacterial, anti-inflammatory, antioxidant, pro-angiogenic, and pro-gliogenic activities. Despite ongoing safety concerns related to the inherent toxicity of mercury, Calomelas and its preparations exhibited an acceptable safety profile when administered in accordance with established clinical protocols.
Calomelas and its preparations are supported by clinical validation and modern pharmacological research, confirming their definite therapeutic efficacy and controllable safety profile. These findings highlight their significant clinical value and broad application prospects in the surgical practice of TCM.
传统上,轻粉及其制剂在中国传统医学(TCM)中被用于治疗疥疮和溃疡,在伤口处理方案中显示出经实证验证的疗效,且至今仍在持续使用。然而,因其汞成分引发了重大担忧,促使现代对此进行审视。至关重要的是,现有文献中仍缺乏对轻粉及其制剂的严格系统评价,这阻碍了它们基于证据的应用和潜在发展。
本综述旨在阐明轻粉及其制剂的药用益处和毒性,支持难治性皮肤溃疡现代治疗方法的开发,同时促进含轻粉制剂安全、合理地融入皮肤科实践。
从科学数据库系统收集轻粉及其制剂的数据,包括PubMed、谷歌学术、美国化学学会出版物、科学网、ScienceDirect、中国知网和万方。
轻粉是一种自唐代起就在中医中使用的汞基化合物,在治疗各种难治性伤口状况方面显示出显著的治疗效果。几种含轻粉的制剂,如生肌玉红膏、八宝丹、拔毒生肌散、太乙膏和轻粉散,在临床实践中常规用于治疗各种皮肤溃疡及顽固性伤口,包括糖尿病足溃疡、术后损伤、压疮和烧伤创面。这些治疗效果的药理学基础依赖于它们的生物活性特性,包括抗菌、抗炎、抗氧化、促血管生成和促神经胶质生成活性。尽管由于汞的固有毒性一直存在安全担忧,但轻粉及其制剂按照既定临床方案给药时显示出可接受的安全性。
轻粉及其制剂得到临床验证和现代药理学研究的支持,证实了它们明确的治疗效果和可控的安全性。这些发现凸显了它们在中医外科实践中的重大临床价值和广阔应用前景。